Ouranidis, A.; Choli-Papadopoulou, T.; Papachristou, E.T.; Papi, R.; Kostomitsopoulos, N.
Biopharmaceutics 4.0, Advanced Pre-Clinical Development of mRNA-Encoded Monoclonal Antibodies to Immunosuppressed Murine Models. Vaccines 2021, 9, 890.
https://doi.org/10.3390/vaccines9080890
AMA Style
Ouranidis A, Choli-Papadopoulou T, Papachristou ET, Papi R, Kostomitsopoulos N.
Biopharmaceutics 4.0, Advanced Pre-Clinical Development of mRNA-Encoded Monoclonal Antibodies to Immunosuppressed Murine Models. Vaccines. 2021; 9(8):890.
https://doi.org/10.3390/vaccines9080890
Chicago/Turabian Style
Ouranidis, Andreas, Theodora Choli-Papadopoulou, Eleni T. Papachristou, Rigini Papi, and Nikolaos Kostomitsopoulos.
2021. "Biopharmaceutics 4.0, Advanced Pre-Clinical Development of mRNA-Encoded Monoclonal Antibodies to Immunosuppressed Murine Models" Vaccines 9, no. 8: 890.
https://doi.org/10.3390/vaccines9080890
APA Style
Ouranidis, A., Choli-Papadopoulou, T., Papachristou, E. T., Papi, R., & Kostomitsopoulos, N.
(2021). Biopharmaceutics 4.0, Advanced Pre-Clinical Development of mRNA-Encoded Monoclonal Antibodies to Immunosuppressed Murine Models. Vaccines, 9(8), 890.
https://doi.org/10.3390/vaccines9080890